Investor's Business Daily on MSN
Roche inks $2.3 billion deal, sending this small biotech stock flying
Nurix Therapeutics stock bounded of its 50-day line Monday after inking a deal with Roche for its BTK-degrading drug, bex-deg ...
Nurix Therapeutics strikes an agreement with Roche to commercialize its lead asset, bexobrutideg.
Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...
If you’re looking to diversify outside of AI, especially as AI investors look to trim their winners to save up for that ...
In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector’s two major indexes — the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) — ...
We just covered the 10 Best Non-AI Stocks to Buy According to Billionaire Stanley Druckenmiller. Revolution Medicines (NASDAQ ...
Merck (NYSE: MRK), and Pfizer (NYSE: PFE) are among the largest pharmaceutical companies in the world. The first focuses ...
Vir Biotechnology develops antibody and RNA-based therapies for infectious diseases, leveraging partnerships and a robust clinical pipeline.
28don MSN
Hantavirus cases spark brief surge in pharma and biotech stocks — here’s why trading is so volatile
The outbreak of Hantavirus on a cruise ship has led to biotech and pharmaceutical stocks surging on reports of firms developing vaccines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results